Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is one biotherapy product originally manufactured by our company with new drug license, and is applying for manufacture license.
  GM-CSF is an essential protein involved in the regulation of both haematopoiesis and functional activity of leucocytes. It can stimulate the proliferation and differentiation of haematopoietic precursor cells, and increase the number of various leucocytes. It can also improve the anti-tumor, anti-infectious effect of neutrophils, macrophages, and esinophils. It can produce big social and economic benefits, if spread it into application.
  The product got scientific achievement certificate awarded by Shanghai scientific and technical committee in 2001.
[Specifications]
100ug/vial,200ug/vial

XINYIHONG
Recombinant Human Erythropoietin (EPO)

  EPO injection is approved by State Drug Administration, and now is in the clinical trial.
  EPO can stimulate the differentiation of bone marrow hematopoiesis stem cell into pronormoblast, speed up erythrocyte proliferation and diferentition, promote hemoglobin synthesis. Most reports show that EPO has an excellent therapeutic effect for anemia associated with chronic renal failure, and anemia of malignancy patients caused by chemotherapy. EPO originally manufactured by our company will finish the clinical trial quickly.

Salcatonin Injection(SCT)

  SCT is approved by Shanghai board of health. we have finished the clinical trial, and now is applying for new drug license.
  The main function of Calcitonin in body is to inhibit the activity of osteocyte and promote the activity of osteoblast. On clinical, it is mainly used as prophylaxis and treatment of osteoporosis and Paget's disease. It can also be used to treat ostealgia, hypercalcaemia, hyperphospheremia etc.